**About the Editor**

**Marco Moschini** completed his medical degree in 2012, at Vita Salute-San Raffaele University—Milan, followed by his PhD in 2016, at Universita Magna Graecia. He embarked upon a one-year fellowship at the Department of Urology of the Mayo Clinic in Rochester in 2015, and a one-year fellowship at the Department of Urology of the General Hospital of Vienna. He spent one year as a surgical robotic fellow in Paris (Institute Mutualiste Montsouris). He has currently in residency in Urology in Luzern (Switzerland), and has been since 2017. Since 2017, Moschini has been an active member of the EAU's Young Academic Urologists' Urothelial Cancer Group. He is an associate editor of *Swiss Urology*, and has been the guest associate editor of an edition of *Translational Andrology and Urology (TAU)*, based on non-muscle invasive bladder cancer, and for an edition of *Arab Journal of Urology*, on the same topic. He is the author of more than 200 peer-reviewed articles in international journals; more than 50 as first author. He serves as reviewer for more than 30 urological and oncological journals. His main interest regards urologic oncology, with a focus on bladder, upper urinary tract and prostate cancers. He is the associated editor for the educational platform of the EAU on urothelial cancer.
